Jefferies Reiterates Buy Rating on IO Biotech (IOBT), PT $8, 'A positive PFS could also provide sig upside potential'
Tweet Send to a Friend
Jefferies analyst Roger Song reiterated a Buy rating and $8.00 price target on IO Biotech (NASDAQ: IOBT)The analyst comments "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
